What does ElevateBio do?

ElevateBio is a biotechnology company based in Waltham, Massachusetts, founded in 2017. It operates as both a contract development and manufacturing organization (CDMO) and an investment holding company, focusing on the development of genetic medicines, cell therapies, and gene-edited therapies. The company partners with biopharmaceutical firms and academic researchers to identify drug targets and bring innovative therapies to market. ElevateBio's ecosystem includes BaseCamp®, a centralized facility for cGMP manufacturing and process development, which supports the production of various therapies, including cell and gene therapies, RNA therapies, and mRNA vaccines. Additionally, the Life Edit® platform utilizes advanced gene editing technologies, including CRISPR, to develop treatments for diseases such as cancer and diabetes. The company employs generative AI to enhance therapeutic development and has established partnerships with over 20 biopharma companies, including Moderna and Novo Nordisk, as well as academic institutions to advance healthcare solutions.